Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Is This For You
FOXO4-DRI is a roughly 5.4 kDa, strongly cationic TAT-fusion peptide, and cationic peptides tend to bind extracellular matrix at the injection site, so subQ delivery could plausibly be substantially lower than IV
If you dont see a lot of bubbles after the first feeding, try a little whole-grain rye flour with the next feeding
49,95 In stock GHK-Cu is a research product from Peptide King (PK) and is intended exclusively for controlled laboratory research
Pharmaceuticals, 18(2), 185
Some practitioners theorize that IV administration might provide advantages for certain applications, though clinical evidence supporting superiority of IV over IM administration for most wellness purposes remains limited
US$ 25.48
US$ 25.55
US$ 22.18
US$ 26.78
US$ 23.53
